Prostate cancer brachytherapy: SFRO guidelines 2021

P. Pommier; M. Ferré; P. Blanchard; Martin; D. Peiffert; S. Robin; J. M. Hannoun-Lévi; V. Marchesi; J. M. Cosset

doi:10.1016/j.canrad.2021.11.019

Prostate cancer brachytherapy: SFRO guidelines 2021

Titre traduit de la contribution: Curiethérapie des cancers de la prostate: recommandations de la SFRO 2021

P. Pommier, M. Ferré, P. Blanchard, Martin, D. Peiffert, S. Robin, J. M. Hannoun-Lévi, V. Marchesi, J. M. Cosset

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

8 Citations (Scopus)

Résumé

Prostate brachytherapy techniques are described, concerning both permanent seed implant and high dose rate brachytherapy. The following guidelines are presented: brachytherapy indications, implant procedure for permanent low dose rate implants and high dose rate with source projector, as well as dose and dose–constraints objectives, immediate postoperative management, post-treatment evaluation, and long-term follow-up.

Titre traduit de la contribution	Curiethérapie des cancers de la prostate: recommandations de la SFRO 2021
langue originale	Anglais
Pages (de - à)	344-355
Nombre de pages	12
journal	Cancer/Radiotherapie
Volume	26
Numéro de publication	1-2
Les DOIs	https://doi.org/10.1016/j.canrad.2021.11.019
état	Publié - 1 févr. 2022

Accès au document

10.1016/j.canrad.2021.11.019

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{6323a8c9593141ecb625b304ad4cfbab,

title = "Prostate cancer brachytherapy: SFRO guidelines 2021",

abstract = "Prostate brachytherapy techniques are described, concerning both permanent seed implant and high dose rate brachytherapy. The following guidelines are presented: brachytherapy indications, implant procedure for permanent low dose rate implants and high dose rate with source projector, as well as dose and dose–constraints objectives, immediate postoperative management, post-treatment evaluation, and long-term follow-up.",

keywords = "Brachytherapy, French society for radiation oncology, Prostate cancer, Recommendations",

author = "P. Pommier and M. Ferr{\'e} and P. Blanchard and Martin and D. Peiffert and S. Robin and Hannoun-L{\'e}vi, {J. M.} and V. Marchesi and Cosset, {J. M.}",

note = "Publisher Copyright: {\textcopyright} 2021",

year = "2022",

month = feb,

day = "1",

doi = "10.1016/j.canrad.2021.11.019",

language = "English",

volume = "26",

pages = "344--355",

journal = "Cancer/Radiotherapie",

issn = "1278-3218",

number = "1-2",

}

TY - JOUR

T1 - Prostate cancer brachytherapy

T2 - SFRO guidelines 2021

AU - Pommier, P.

AU - Ferré, M.

AU - Blanchard, P.

AU - Martin,

AU - Peiffert, D.

AU - Robin, S.

AU - Hannoun-Lévi, J. M.

AU - Marchesi, V.

AU - Cosset, J. M.

PY - 2022/2/1

Y1 - 2022/2/1

N2 - Prostate brachytherapy techniques are described, concerning both permanent seed implant and high dose rate brachytherapy. The following guidelines are presented: brachytherapy indications, implant procedure for permanent low dose rate implants and high dose rate with source projector, as well as dose and dose–constraints objectives, immediate postoperative management, post-treatment evaluation, and long-term follow-up.

AB - Prostate brachytherapy techniques are described, concerning both permanent seed implant and high dose rate brachytherapy. The following guidelines are presented: brachytherapy indications, implant procedure for permanent low dose rate implants and high dose rate with source projector, as well as dose and dose–constraints objectives, immediate postoperative management, post-treatment evaluation, and long-term follow-up.

KW - Brachytherapy

KW - French society for radiation oncology

KW - Prostate cancer

KW - Recommendations

UR - http://www.scopus.com/inward/record.url?scp=85124190715&partnerID=8YFLogxK

U2 - 10.1016/j.canrad.2021.11.019

DO - 10.1016/j.canrad.2021.11.019

M3 - Article

C2 - 34955422

AN - SCOPUS:85124190715

SN - 1278-3218

VL - 26

SP - 344

EP - 355

JO - Cancer/Radiotherapie

JF - Cancer/Radiotherapie

IS - 1-2

ER -